Literature DB >> 23500538

Analysis by liquid chromatography-mass spectrometry of sterols and oxysterols in brain of the newborn Dhcr7(Δ3-5/T93M) mouse: a model of Smith-Lemli-Opitz syndrome.

Anna Meljon1, Gordon L Watson, Yuqin Wang, Cedric H L Shackleton, William J Griffiths.   

Abstract

In this study the sterol and oxysterol profile of newborn brain from the Dhcr7(Δ3-5/T93M) mouse model of Smith-Lemli-Opitz syndrome (SLOS) has been investigated. This is a viable mouse model which is compound heterozygous containing one null allele and one T93M mutation on Dhcr7. We find the SLOS mouse has reduced levels of cholesterol and desmosterol and increased levels of 7- and 8-dehydrocholesterol and of 7- and 8-dehydrodesmosterol in brain compared to the wild type. The profile of enzymatically formed oxysterols in the SLOS mouse resembles that in the wild type but the level of 24S-hydroxycholesterol, the dominating cholesterol metabolite, is reduced in a similar proportion to that of cholesterol. A number of oxysterols abundant in the SLOS mouse are probably derived from 7-dehydrocholesterol, however, the mechanism of their formation is unclear.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23500538      PMCID: PMC4004445          DOI: 10.1016/j.bcp.2013.03.003

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  36 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

2.  Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysis.

Authors:  Andrea E DeBarber; Yana Sandlers; Anuradha S Pappu; Louise S Merkens; P Barton Duell; Steven R Lear; Sandra K Erickson; Robert D Steiner
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-11-23       Impact factor: 3.205

3.  Lipid biomarkers of oxidative stress in a genetic mouse model of Smith-Lemli-Opitz syndrome.

Authors:  Zeljka Korade; Libin Xu; Karoly Mirnics; Ned A Porter
Journal:  J Inherit Metab Dis       Date:  2012-06-21       Impact factor: 4.982

4.  An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell/mouse models for Smith-Lemli-Opitz syndrome.

Authors:  Libin Xu; Zeljka Korade; Dale A Rosado; Wei Liu; Connor R Lamberson; Ned A Porter
Journal:  J Lipid Res       Date:  2011-03-14       Impact factor: 5.922

5.  cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain.

Authors:  E G Lund; J M Guileyardo; D W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

6.  Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome.

Authors:  L E Kratz; R I Kelley
Journal:  Am J Med Genet       Date:  1999-02-19

7.  Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol.

Authors:  Maura Heverin; Steve Meaney; Anat Brafman; Millicent Shafir; Maria Olin; Marjan Shafaati; Sara von Bahr; Lilian Larsson; Anita Lövgren-Sandblom; Ulf Diczfalusy; Paolo Parini; Elena Feinstein; Ingemar Björkhem
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-30       Impact factor: 8.311

8.  Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome).

Authors:  Josep Marcos; Cedric H L Shackleton; Madhavee M Buddhikot; Forbes D Porter; Gordon L Watson
Journal:  Steroids       Date:  2007-07-13       Impact factor: 2.668

9.  Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme.

Authors:  S Andersson; D L Davis; H Dahlbäck; H Jörnvall; D W Russell
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

10.  Metabolism of 4 beta -hydroxycholesterol in humans.

Authors:  Karl Bodin; Ulla Andersson; Eva Rystedt; Ewa Ellis; Maria Norlin; Irina Pikuleva; Gösta Eggertsen; Ingemar Björkhem; Ulf Diczfalusy
Journal:  J Biol Chem       Date:  2002-06-20       Impact factor: 5.157

View more
  11 in total

1.  Endogenous B-ring oxysterols inhibit the Hedgehog component Smoothened in a manner distinct from cyclopamine or side-chain oxysterols.

Authors:  Navdar Sever; Randall K Mann; Libin Xu; William J Snell; Carmen I Hernandez-Lara; Ned A Porter; Philip A Beachy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

2.  Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Intermediates of the Cholesterol Biosynthetic Pathway in Primary Cultured Rat Hepatocytes.

Authors:  Elizabeth A Rondini; Asmita Pant; Thomas A Kocarek
Journal:  J Pharmacol Exp Ther       Date:  2015-10-01       Impact factor: 4.030

3.  A highly sensitive method for analysis of 7-dehydrocholesterol for the study of Smith-Lemli-Opitz syndrome.

Authors:  Wei Liu; Libin Xu; Connor Lamberson; Dorothea Haas; Zeljka Korade; Ned A Porter
Journal:  J Lipid Res       Date:  2013-11-20       Impact factor: 5.922

4.  Oxidative stress, serotonergic changes and decreased ultrasonic vocalizations in a mouse model of Smith-Lemli-Opitz syndrome.

Authors:  N F Sharif; Z Korade; N A Porter; F E Harrison
Journal:  Genes Brain Behav       Date:  2017-03-15       Impact factor: 3.449

5.  7-Dehydrocholesterol Encapsulated Polymeric Nanoparticles As a Radiation-Responsive Sensitizer for Enhancing Radiation Therapy.

Authors:  Ian Delahunty; Jianwen Li; Wen Jiang; Chaebin Lee; Xueyuan Yang; Anil Kumar; Zhi Liu; Weizhong Zhang; Jin Xie
Journal:  Small       Date:  2022-03-18       Impact factor: 15.153

6.  Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.

Authors:  William J Griffiths; Jonas Abdel-Khalik; Peter J Crick; Michael Ogundare; Cedric H Shackleton; Karin Tuschl; Mei Kwun Kwok; Brian W Bigger; Andrew A Morris; Akira Honda; Libin Xu; Ned A Porter; Ingemar Björkhem; Peter T Clayton; Yuqin Wang
Journal:  J Steroid Biochem Mol Biol       Date:  2016-03-11       Impact factor: 4.292

7.  Pathogenesis, Epidemiology, Diagnosis and Clinical Aspects of Smith-Lemli-Opitz Syndrome.

Authors:  Simona E Bianconi; Joanna L Cross; Christopher A Wassif; Forbes D Porter
Journal:  Expert Opin Orphan Drugs       Date:  2015-03       Impact factor: 0.694

8.  Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome.

Authors:  Steven J Fliesler; Neal S Peachey; Josi Herron; Kelly M Hines; Nadav I Weinstock; Sriganesh Ramachandra Rao; Libin Xu
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

9.  Neuronal Cholesterol Accumulation Induced by Cyp46a1 Down-Regulation in Mouse Hippocampus Disrupts Brain Lipid Homeostasis.

Authors:  Sophie Ayciriex; Fathia Djelti; Sandro Alves; Anne Regazzetti; Mathieu Gaudin; Jennifer Varin; Dominique Langui; Ivan Bièche; Eloise Hudry; Delphine Dargère; Patrick Aubourg; Nicolas Auzeil; Olivier Laprévote; Nathalie Cartier
Journal:  Front Mol Neurosci       Date:  2017-07-11       Impact factor: 5.639

Review 10.  Lipid metabolism fattens up hedgehog signaling.

Authors:  Robert Blassberg; John Jacob
Journal:  BMC Biol       Date:  2017-10-26       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.